Filing Details
- Accession Number:
- 0001104659-21-088377
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-01 18:30:12
- Reporting Period:
- 2021-07-01
- Accepted Time:
- 2021-07-01 18:30:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773427 | Springworks Therapeutics Inc. | SWTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1786966 | Badreddin Edris | C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-07-01 | 32,000 | $85.35 | 301,541 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $82.01 to $87.12, inclusive
- Includes 101,038 restricted stock awards subject to time-based vesting.